
FDA Class II Recall Hits 51,762 Units of ORL Labs Oral Care Products Over Hormone Contamination
The U.S. Food and Drug Administration (FDA) has classified a voluntary recall of 51,762 units of ORL Labs LLC oral care products as Class II after testing detected hormones in samples. The recall, initiated on October 12, 2026, and classified on November 6, 2026, affects six toothpaste and mouthwash products for adults and children. The FDA did not specify hormone concentrations or the cause of cross-contamination, and no illnesses have been reported.













